Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma

Intern Med. 2003 May;42(5):416-20. doi: 10.2169/internalmedicine.42.416.

Abstract

A 39-year-old man was diagnosed with hepatitis B virus-related cirrhosis, and because of hepatic exacerbations with icterus and ascites, he had been repeatedly hospitalized. He was treated with lamivudine. Several months later, his ascites disappeared and his liver function was improved from class C to A according to the Child-Pugh classification. Two years later, one small hepatocellular carcinoma was detected, and he underwent a successful hepatectomy. From this case, we consider lamivudine to be useful for improving hepatic function in decompensated liver cirrhosis type B and lamivudine might enable surgical resection of hepatocellular carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Carcinoma, Hepatocellular / etiology
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / surgery*
  • Hepatectomy
  • Hepatitis B / complications
  • Hepatitis B / drug therapy*
  • Humans
  • Lamivudine / therapeutic use*
  • Liver Cirrhosis / diagnostic imaging
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / etiology
  • Liver Neoplasms / etiology
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery*
  • Male
  • Radiography

Substances

  • Antiviral Agents
  • Lamivudine